A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis by Weisel, K, Berger, S, Thorn, K, Taylor, PC, Peterfy, C, Siddall, H, Tompson, D, Wang, S, Quattrocchi, E, Burriss, SW, Walter, J, Tak, PP